Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Diabetes Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Diabetes Devices Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Diabetes Devices Market: Type Movement Analysis
4.3. Diabetes Devices Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. BGM Devices
4.5.1. BGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Self Monitoring Devices
4.5.2.1. Self Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2. Blood Glucose Meter
4.5.2.2.1. Blood Glucose Meter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Testing Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Lancets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Continous Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Sensors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3.3. Transmitter
4.5.3.3.1. Transmitters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Receivers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Insulin Delivery Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Pens
4.6.2.1. Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Pumps
4.6.3.1. Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Syringes
4.6.4.1. Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Jet Injector
4.6.5.1. Jet Injector Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Diabetes Devices Market: Distribution Channel Movement Analysis
5.3. Diabetes Devices Market by Distribution Channel Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Hospital Pharmacies
5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Retail Pharmacies
5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diabetes Clinics/ Centers
5.7.1. Diabetes Clinics/ Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Online Pharmacies
5.8.1. Online PharmaciesMarket Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Diabetes Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Diabetes Devices Market: End Use Movement Analysis
6.3. Diabetes Devices Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Dignostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Homecare
6.7.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Diabetes Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Diabetes Devices Market Movement Analysis
7.3. Diabetes Devices Market: Regional Estimates & Trend Analysis by Type & Distribution Channel
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. North America
7.5.1. North America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. Europe
7.5.5. Europe Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. UK
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement scenario
7.5.6.5. UK Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Germany
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Germany Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. France
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. France Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Italy
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. Italy Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.10. Spain
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Spain Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.11. Denmark
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Denmark Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.12. Sweden
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Sweden Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.13. Norway
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Norway Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Mexico
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Mexico Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.4. Argentina
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Reimbursement scenario
7.7.4.5. Argentina Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Diabetes Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Medtronic plc
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Abbott Laboratories
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. F.Hoffmann-La-Ltd.
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Bayer AG
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Lifescan, Inc.
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. B Braun Melsungen AG
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Lifescan, Inc.
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Dexcom Inc.
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Insulet Corporation
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Ypsomed Holdings
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Product Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. Companion Medical
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Product Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. Sanofi
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Product Benchmarking
8.2.12.4. Strategic Initiatives
8.2.13. Valeritas Holding Inc.
8.2.13.1. Company Overview
8.2.13.2. Financial Performance
8.2.13.3. Product Benchmarking
8.2.13.4. Strategic Initiatives
8.2.14. Novo Nordisk
8.2.14.1. Company Overview
8.2.14.2. Financial Performance
8.2.14.3. Product Benchmarking
8.2.14.4. Strategic Initiatives
8.2.15. Arkray, Inc.
8.2.15.1. Company Overview
8.2.15.2. Financial Performance
8.2.15.3. Product Benchmarking
8.2.15.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 4. Global diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 5. Global Diabetes Devices market, by end use, 2021 - 2033 (USD Million)
Table 6. North America diabetes devices market, by country, 2021 - 2033 (USD Million)
Table 7. North America diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 8. North America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 9. North America diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 10. U.S. diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 11. U.S. diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 12. U.S. diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 13. Canada diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 14. Canada diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 15. Canada diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 16. Europe diabetes devices market, by country, 2021 - 2033 (USD Million)
Table 17. Europe diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 18. Europe diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 19. Europe diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 20. UK diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 21. UK diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 22. UK diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 23. Germany diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 24. Germany diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 25. Germany diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 26. France diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 27. France diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 28. France diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 29. Italy diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 30. Italy diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 31. Italy diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 32. Denmark diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 33. Denmark diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 34. Denmark diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 35. Sweden diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 36. Sweden diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 37. Sweden diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 38. Norway diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 39. Norway diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 40. Norway diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 41. Asia Pacific diabetes devices market, by country, 2021 - 2033 (USD Million)
Table 42. Asia Pacific diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 43. Asia Pacific diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 44. Asia Pacific diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 45. Japan diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 46. Japan diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 47. Japan diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 48. China diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 49. China diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 50. China diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 51. India diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 52. India diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 53. India diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 54. Australia diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 55. Australia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 56. Australia diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 57. South Korea diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 58. South Korea diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 59. South Korea diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 60. Thailand diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 61. Thailand diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 62. Thailand diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 63. Latin America diabetes devices market, by Country, 2021 - 2033 (USD Million)
Table 64. Latin America diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 65. Latin America diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 66. Latin America diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 67. Brazil diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 68. Brazil diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 69. Brazil diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 70. Mexico diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 71. Mexico diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 72. Mexico diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 73. Argentina diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 74. Argentina diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 75. Argentina diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 76. Middle East & Africa diabetes devices market, by country, 2021 - 2033 (USD Million)
Table 77. Middle East & Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 78. Middle East & Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 79. Middle East & Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 80. South Africa diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 81. South Africa diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 82. South Africa diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 83. Saudi Arabia diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 84. Saudi Arabia diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 85. Saudi Arabia diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 86. UAE diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 87. UAE diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 88. UAE diabetes devices market, by end use, 2021 - 2033 (USD Million)
Table 89. Kuwait diabetes devices market, by type, 2021 - 2033 (USD Million)
Table 90. Kuwait diabetes devices market, by distribution channel, 2021 - 2033 (USD Million)
Table 91. Kuwait diabetes devices market, by end use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Diabetes devices market: Market outlook
Fig. 14 Diabetes devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Diabetes devices market driver impact
Fig. 20 Diabetes devices market restraint impact
Fig. 21 Diabetes devices market: type movement analysis
Fig. 22 Diabetes devices market: type outlook and key takeaways
Fig. 23 Blood glucose monitoring devices market estimates and forecast, 2021 - 2033
Fig. 24 Self-monitoring devices market estimates and forecast, 2021 - 2033
Fig. 25 Blood glucose meters market estimates and forecast, 2021 - 2033
Fig. 26 Testing strips market estimates and forecast, 2021 - 2033
Fig. 27 Lancets market estimates and forecast, 2021 - 2033
Fig. 28 Continuous glucose monitoring devices market estimates and forecast, 2021 - 2033
Fig. 29 Sensors market estimates and forecast, 2021 - 2033
Fig. 30 Transmitters market estimates and forecast, 2021 - 2033
Fig. 31 Receivers market estimates and forecast, 2021 - 2033
Fig. 32 Insulin delivery devices market estimates and forecast, 2021 - 2033
Fig. 33 Pumps market estimates and forecast, 2021 - 2033
Fig. 34 Pens market estimates and forecast, 2021 - 2033
Fig. 35 Syringes market estimates and forecast, 2021 - 2033
Fig. 36 Jet injectors market estimates and forecast, 2021 - 2033
Fig. 37 Diabetes devices market: distribution channel movement analysis
Fig. 38 Diabetes devices market: distribution channel outlook and key takeaways
Fig. 39 Hospital pharmacies market estimates and forecast, 2021 - 2033
Fig. 40 Retail pharmacies market estimates and forecast, 2021 - 2033
Fig. 41 Diabetes clinics/centers market estimates and forecast, 2021 - 2033
Fig. 42 Online pharmacies market estimates and forecast, 2021 - 2033
Fig. 43 Others market estimates and forecast, 2021 - 2033
Fig. 44 Diabetes devices market: end use movement analysis
Fig. 45 Diabetes devices market: end use outlook and key takeaways
Fig. 46 Hospitals market estimates and forecast, 2021 - 2033
Fig. 47 Diagnostic centers market estimates and forecast, 2021 - 2033
Fig. 48 Homecare market estimates and forecast, 2021 - 2033
Fig. 49 Global Diabetes devices market: regional movement analysis
Fig. 50 Global Diabetes devices market: regional outlook and key takeaways
Fig. 51 North America
Fig. 52 North America market estimates and forecast, 2021 - 2033
Fig. 53 US
Fig. 54 US market estimates and forecast, 2021 - 2033
Fig. 55 Canada
Fig. 56 Canada market estimates and forecast, 2021 - 2033
Fig. 57 Europe
Fig. 58 Europe market estimates and forecast, 2021 - 2033
Fig. 59 UK
Fig. 60 UK market estimates and forecast, 2021 - 2033
Fig. 61 Germany
Fig. 62 Germany market estimates and forecast, 2021 - 2033
Fig. 63 France
Fig. 64 France market estimates and forecast, 2021 - 2033
Fig. 65 Italy
Fig. 66 Italy market estimates and forecast, 2021 - 2033
Fig. 67 Spain
Fig. 68 Spain market estimates and forecast, 2021 - 2033
Fig. 69 Denmark
Fig. 70 Denmark market estimates and forecast, 2021 - 2033
Fig. 71 Sweden
Fig. 72 Sweden market estimates and forecast, 2021 - 2033
Fig. 73 Norway
Fig. 74 Norway market estimates and forecast, 2021 - 2033
Fig. 75 Asia Pacific
Fig. 76 Asia Pacific market estimates and forecast, 2021 - 2033
Fig. 77 Japan
Fig. 78 Japan market estimates and forecast, 2021 - 2033
Fig. 79 China
Fig. 80 China market estimates and forecast, 2021 - 2033
Fig. 81 India
Fig. 82 India market estimates and forecast, 2021 - 2033
Fig. 83 South Korea
Fig. 84 South Korea market estimates and forecast, 2021 - 2033
Fig. 85 Thailand
Fig. 86 Thailand market estimates and forecast, 2021 - 2033
Fig. 87 Australia
Fig. 88 Australia market estimates and forecast, 2021 - 2033
Fig. 89 Latin America
Fig. 90 Latin America market estimates and forecast, 2021 - 2033
Fig. 91 Brazil
Fig. 92 Brazil market estimates and forecast, 2021 - 2033
Fig. 93 Mexico
Fig. 94 Mexico market estimates and forecast, 2021 - 2033
Fig. 95 Argentina
Fig. 96 Argentina market estimates and forecast, 2021 - 2033
Fig. 97 Middle East and Africa
Fig. 98 Middle East and Africa market estimates and forecast, 2021 - 2033
Fig. 99 Saudi Arabia
Fig. 100 Saudi Arabia market estimates and forecast, 2021 - 2033
Fig. 101 South Africa
Fig. 102 South Africa market estimates and forecast, 2021 - 2033
Fig. 103 UAE
Fig. 104 UAE market estimates and forecast, 2021 - 2033
Fig. 105 Kuwait
Fig. 106 Kuwait market estimates and forecast, 2021 - 2033
Fig. 107 Participant categorization - Diabetes devices market
Fig. 108 Market share of key market players - Diabetes devices market
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
